Simvastatin Inhibits LPS-induced Alveolar Bone Loss during Metabolic Syndrome

被引:39
|
作者
Jin, J. [1 ,5 ]
Machado, E. R. [3 ,4 ]
Yu, H. [3 ,4 ]
Zhang, X. [1 ]
Lu, Z. [1 ]
Li, Y. [1 ]
Lopes-Virella, M. F. [1 ,2 ]
Kirkwood, K. L. [3 ,4 ]
Huang, Y. [1 ,2 ]
机构
[1] Med Univ S Carolina, Coll Med, Dept Med, Div Endocrinol Diabet & Med Genet, Charleston, SC 29425 USA
[2] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC USA
[3] Med Univ S Carolina, Coll Dent Med, Dept Craniofacial Biol, Charleston, SC 29425 USA
[4] Med Univ S Carolina, Coll Dent Med, Ctr Oral Hlth Res, Charleston, SC 29425 USA
[5] Guilin Med Univ, Affiliated Hosp, Lab Hepatobiliary & Pancreat Surg, Guilin 541001, Guangxi, Peoples R China
基金
美国国家卫生研究院;
关键词
lipopolysaccharide; inflammation obesity; periodontal disease; statin; insulin resistance; PERIODONTAL-DISEASE; STATIN THERAPY; CARDIOVASCULAR-DISEASE; TNF-ALPHA; OBESITY; INFLAMMATION; ASSOCIATION; METAANALYSIS; ARTHRITIS; MICE;
D O I
10.1177/0022034513516980
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Studies in recent years have shown a positive relationship between metabolic syndrome (MS) and periodontal disease (PD). Given that patients with MS take statins to reduce cholesterol, and statins also have anti-inflammatory effects, it is important to determine if statin intake hinders the progression of MS-associated PD. In this study, PD was induced in Zucker fat rats (ZFRs), an animal model for MS, and in control lean rats by periodontal injection of Aggregatibacter actinomycetemcomitans lipopolysaccharide (LPS), while simvastatin was given to some of the rats via gavage. After 4 wk of treatment, alveolar bone loss was determined by micro-computed tomography. To explore the underlying mechanisms, we determined the effect of simvastatin on tissue inflammation and the expression of molecules involved in osteoclastogenesis. Results showed that while bone loss was increased by LPS in both ZFRs and the control lean rats, it was significantly more in the former than the latter. Simvastatin effectively alleviated bone loss in both ZFRs and the control rats. Results also showed that LPS stimulated leukocyte tissue infiltration and expression of molecules for osteoclastogenesis, but simvastatin significantly modulated the stimulation. This study demonstrated that simvastatin inhibited LPS-induced alveolar bone loss and periodontal tissue inflammation in rats with MS.
引用
收藏
页码:294 / 299
页数:6
相关论文
共 50 条
  • [1] Rapamycin Inhibits Osteoclastogenesis and Prevents LPS-Induced Alveolar Bone Loss by Oxidative Stress Suppression
    Feng, Chong
    Liu, Yan
    Zhang, Bao-Yi
    Zhang, Hao
    Shan, Fa-Yu
    Li, Tian-Qi
    Zhao, Zhi-Ning
    Wang, Xin-Xing
    Zhang, Xiang-Yu
    ACS OMEGA, 2023, 8 (23): : 20739 - 20754
  • [2] CMT-8/clodronate combination therapy synergistically inhibits alveolar bone loss in LPS-induced periodontitis
    Llavaneras, A
    Golub, LM
    Rifkin, BR
    Heikkilä, P
    Sorsa, T
    Teronen, O
    Salo, T
    Liu, Y
    Ryan, ME
    Ramamurthy, NS
    INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC APPLICATIONS, 1999, 878 : 671 - 674
  • [3] PTPRO inhibits LPS-induced apoptosis in alveolar epithelial cells
    Li, Xuemeng
    Xiong, Qianqian
    Yang, Qingqing
    Shi, Jing
    Han, Yuhong
    Dong, Yishu
    Qian, Jun
    Qian, Zhongqing
    Wang, Hongtao
    Wang, Ting
    Wu, Fengjiao
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2024, 718
  • [4] Insulin inhibits LPS-induced signaling pathways in alveolar macrophages
    Martins, Joilson O.
    Ferracini, Matheus
    Ravanelli, Natalia
    Landgraf, Richardt G.
    Jancar, Sonia
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2008, 21 (04) : 297 - 304
  • [5] Rapamycin Inhibits Osteoclastogenesis and Prevents LPS-Induced Alveolar Bone Loss by Oxidative Stress Suppression (vol 8, pg 20739, 2023)
    Feng, Chong
    Liu, Yan
    Zhang, Bao-Yi
    Zhang, Hao
    Shan, Fa-Yu
    Li, Tian-Qi
    Zhao, Zhi-Ning
    Wang, Xin-Xing
    Zhang, Xiang-Yu
    ACS OMEGA, 2023, 8 (44): : 42005 - 42005
  • [6] Artesunate inhibits RANKL-induced osteoclastogenesis and bone resorption in vitro and prevents LPS-induced bone loss in vivo
    Wei, Cheng-Ming
    Liu, Qian
    Song, Fang-Ming
    Lin, Xi-Xi
    Su, Yi-Ji
    Xu, Jiake
    Huang, Lin
    Zong, Shao-Hui
    Zhao, Jin-Min
    JOURNAL OF CELLULAR PHYSIOLOGY, 2018, 233 (01) : 476 - 485
  • [7] LPS-induced premature osteocyte senescence: Implications in inflammatory alveolar bone loss and periodontal disease pathogenesis
    Aquino-Martinez, Ruben
    Rowsey, Jennifer L.
    Fraser, Daniel G.
    Eckhardt, Brittany A.
    Khosla, Sundeep
    Farr, Joshua N.
    Monroe, David G.
    BONE, 2020, 132
  • [8] Simvastatin inhibits lipopolysaccharide-induced osteoclastogenesis and reduces alveolar bone loss in experimental periodontal disease
    Jin, J.
    Zhang, X.
    Lu, Z.
    Li, Y.
    Lopes-Virella, M. F.
    Yu, H.
    Haycraft, C. J.
    Li, Q.
    Kirkwood, K. L.
    Huang, Y.
    JOURNAL OF PERIODONTAL RESEARCH, 2014, 49 (04) : 518 - 526
  • [9] Scutellarein inhibits RANKL-induced osteoclast formation in vitro and prevents LPS-induced bone loss in vivo
    Fu, Fangsheng
    Shao, Siyuan
    Wang, Ziyi
    Song, Fangming
    Lin, Xixi
    Ding, Jiaxin
    Li, Chen
    Wu, Zuoxing
    Li, Kai
    Xiao, Yu
    Su, Yiji
    Zhao, Jinmin
    Liu, Qian
    Xu, Jiake
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (07) : 11951 - 11959
  • [10] Simvastatin inhibits LPS-induced LDL uptake through suppression of EL expression in macrophages
    Yasuda, T.
    Hirata, K.
    Ishida, T.
    Kojima, Y.
    Tanaka, H.
    Okada, T.
    Taira, K.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 498 - 498